Terug
22
Dagbereik
€ 111,74
€ 116,40
52-Weeksbereik
€ 96,43
€ 160,27
Volume
1.290.498
50D / 200D Gem.
€ 127,46
/
€ 129,95
Vorige Slotkoers
€ 114,20
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 24,5 | 0,3 |
| P/B | 4,7 | 3,0 |
| ROE % | 20,6 | 3,7 |
| Net Margin % | 18,8 | 3,8 |
| Rev Growth 5Y % | 2,4 | 10,0 |
| D/E | 0,5 | 0,2 |
Koersdoel Analisten
Hold
€ 165,00
+46.0%
Low: € 130,00
High: € 180,00
Forward K/W
18,94
Forward WPA
€ 5,97
WPA Groei (sch.)
+0,0%
Omzet Sch.
7,39B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 8,58
€ 8,47 – € 8,69
|
9,26B | 1 |
| FY2029 |
€ 8,04
€ 7,93 – € 8,14
|
8,81B | 1 |
| FY2028 |
€ 7,29
€ 6,75 – € 7,71
|
8,35B | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | € 1,37 | € 1,36 | -0,7% |
| 2025-11-24 | € 1,58 | € 1,59 | +0,4% |
| 2025-08-27 | € 1,37 | € 1,37 | 0,0% |
| 2025-05-28 | € 1,26 | € 1,31 | +4,0% |
| 2025-02-26 | € 1,28 | € 1,31 | +2,3% |
| 2024-11-25 | € 1,41 | € 1,46 | +3,5% |
| 2024-08-21 | € 1,26 | € 1,32 | +4,8% |
| 2024-05-29 | € 1,19 | € 1,22 | +2,5% |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,22%
Growth (3Y)
-11,27%
Growth (5Y)
6,62%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Apr 22, 2026 | € 0,26 | 0,89% |
| Jan 06, 2026 | Jan 28, 2026 | € 0,26 | 0,68% |
| Sep 30, 2025 | Oct 22, 2025 | € 0,25 | 0,77% |
| Jul 01, 2025 | Jul 23, 2025 | € 0,25 | 0,81% |
| Apr 01, 2025 | Apr 23, 2025 | € 0,25 | 0,85% |
| Dec 31, 2024 | Jan 22, 2025 | € 0,25 | 0,71% |
| Oct 01, 2024 | Oct 23, 2024 | € 0,24 | 0,64% |
| Jul 02, 2024 | Jul 24, 2024 | € 0,24 | 0,74% |
| Apr 01, 2024 | Apr 24, 2024 | € 0,24 | 0,63% |
| Dec 29, 2023 | Jan 24, 2024 | € 0,24 | 0,66% |
| Oct 02, 2023 | Oct 25, 2023 | € 0,23 | 0,81% |
| Jun 30, 2023 | Jul 26, 2023 | € 0,23 | 0,74% |
| Apr 03, 2023 | Apr 26, 2023 | € 0,23 | 0,63% |
| Dec 30, 2022 | Jan 25, 2023 | € 0,23 | 0,57% |
| Oct 03, 2022 | Oct 26, 2022 | € 0,21 | 0,66% |
| Jul 01, 2022 | Jul 27, 2022 | € 0,21 | 0,69% |
| Apr 04, 2022 | Apr 27, 2022 | € 0,21 | 0,60% |
| Jan 03, 2022 | Jan 26, 2022 | € 0,21 | 0,51% |
| Oct 04, 2021 | Oct 27, 2021 | € 0,19 | 0,51% |
| Jul 02, 2021 | Jul 28, 2021 | € 0,19 | 0,51% |
Belangrijkste Punten
Revenue grew 2,40% annually over 5 years — modest growth
ROE of 20,62% indicates high profitability
Net margin of 18,75% shows strong profitability
Debt/Equity of 0,50 — conservative balance sheet
Generating 1,15B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,33%
Groei
Revenue Growth (5Y)
2,40%
Revenue (1Y)6,73%
Earnings (1Y)1,09%
FCF Growth (3Y)-11,59%
Kwaliteit
Return on Equity
20,62%
ROIC10,99%
Net Margin18,75%
Op. Margin21,29%
Veiligheid
Debt / Equity
0,50
Current Ratio1,96
Interest Coverage13,21
Waardering
P/E Ratio
24,53
Forward P/E18,77
P/B Ratio4,74
EV/EBITDA22,67
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,73% | Revenue Growth (3Y) | 0,84% |
| Earnings Growth (1Y) | 1,09% | Earnings Growth (3Y) | 2,51% |
| Revenue Growth (5Y) | 2,40% | Earnings Growth (5Y) | 1,87% |
| Profitability | |||
| Revenue (TTM) | 6,95B | Net Income (TTM) | 1,30B |
| ROE | 20,62% | ROA | 10,24% |
| Gross Margin | 52,43% | Operating Margin | 21,29% |
| Net Margin | 18,75% | Free Cash Flow (TTM) | 1,15B |
| ROIC | 10,99% | FCF Growth (3Y) | -11,59% |
| Safety | |||
| Debt / Equity | 0,50 | Current Ratio | 1,96 |
| Interest Coverage | 13,21 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,22% |
| Dividend Growth (3Y) | -11,27% | Dividend Growth (5Y) | 6,62% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 24,53 | Forward P/E | 18,77 |
| P/B Ratio | 4,74 | P/S Ratio | 4,60 |
| PEG Ratio | 9,41 | Forward PEG | N/A |
| EV/EBITDA | 22,67 | Fwd EV/EBITDA | 16,69 |
| Forward P/S | 4,32 | Fwd Earnings Yield | 5,33% |
| FCF Yield | 3,60% | ||
| Market Cap | 31,96B | Enterprise Value | 33,52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6,95B | 6,51B | 6,83B | 6,85B | 6,32B |
| Net Income | 1,30B | 1,29B | 1,24B | 1,25B | 1,21B |
| EPS (Diluted) | 4,57 | 4,43 | 4,19 | 4,18 | 3,94 |
| Gross Profit | 3,64B | 3,54B | 3,47B | 3,72B | 3,41B |
| Operating Income | 1,48B | 1,49B | 1,35B | 1,62B | 1,35B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12,73B | 11,85B | 10,76B | 10,53B | 10,71B |
| Total Liabilities | 5,99B | 5,95B | 4,92B | 5,23B | 5,32B |
| Shareholders' Equity | 6,74B | 5,90B | 5,85B | 5,31B | 5,39B |
| Total Debt | 3,35B | 3,57B | 2,74B | 2,77B | 2,73B |
| Cash & Equivalents | 1,79B | 1,33B | 1,59B | 1,05B | 1,48B |
| Current Assets | 4,59B | 3,96B | 4,19B | 3,78B | 3,80B |
| Current Liabilities | 2,35B | 1,90B | 1,60B | 1,86B | 1,71B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#959 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026